The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study

Moran, Paul; Romaniuk, Helena; Coffey, Carolyn; Chanen, Andrew M; Degenhardt, Louisa; Borschmann, Rohan; Patton, George C.

doi:10.1016/s2215-0366(16)30029-3

Cited by 99 publications

(83 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Only relatively recently have PDs, and particularly borderline PD, become recognized as common mental disorders associated with increased long-term impairment, morbidity, and mortality among adults (Fok et al, 2014; Quirk et al, 2016). For adolescents, our recognition of PDs as diagnosable conditions (Bjorkenstam, Bjorkenstam, Holm, Gerdin, & Ekselius, 2015; Sharp & Fonagy, 2015) with very serious long-term implications for mental health and social functioning (Moran et al, 2016) is even more recent. This recognition has had a strong and positive impact on the development, adaptation, and implementation of treatments for patients, particularly young people (Chanen, 2015).…”

Section: The Icd-11 Proposal: Limitations Of a Purely Dimensional Appmentioning

confidence: 99%

The Challenge of Transforming the Diagnostic System of Personality Disorders

Herpertz

Huprich

Bohus

et al. 2017

Journal of Personality Disorders

Self Cite

140

100

View full text Add to dashboard Cite

While the DSM-5 alternative model of personality disorder (PD) diagnosis allows the field to systematically compare categorical and dimensional classifications, the ICD-11 proposal suggests a radical change by restricting the classification of PDs to one category, deleting all specific types, basing clinical service provision exclusively upon a severity dimension, and restricting trait domains to secondary qualifiers without defining cutoff points. This article reflects broad international agreement about the state of PD diagnosis. It is argued that diagnosis according to the ICD-11 proposal is based on broad, potentially stigmatizing descriptions of impaired functioning and ignores much of the impressive body of research and treatment guidelines that have advanced the care of adults and adolescents with borderline and other PDs. Before radically changing classification, which highly impacts the provision of health care, head-to-head field trials coupled with the views of patients as well as thorough debate among scientists are urgently needed.

show abstract

Section: The Icd-11 Proposal: Limitations Of a Purely Dimensional Appmentioning

confidence: 99%

The Challenge of Transforming the Diagnostic System of Personality Disorders

Herpertz

Huprich

Bohus

et al. 2017

Journal of Personality Disorders

Self Cite

140

100

View full text Add to dashboard Cite

show abstract

“…Around 6% of the world population and 12% of Western countries are estimated to meet the criteria for a personality disorder (PD), which is a critical global risk factor for both mental, social and physical problems . Thus, assessment of PD in public health research as well as clinical practice is vital.…”

Section: Introductionmentioning

confidence: 99%

Structure of DSM‐5 and ICD‐11 personality domains in Iranian community sample

Lotfi

Bach

Amini

et al. 2018

Personality & Mental Health

View full text Add to dashboard Cite

show abstract

“…Personality disorders are common long-term mental health conditions associated with social disadvantage, poor health and reduced life expectancy. [1][2][3] The management of individuals with personality disorder is associated with substantial health-care costs, 4 and the presence of co-morbid personality pathology is generally associated with a poorer treatment outcome for other health conditions. 5 Individuals with personality disorder suffer from high rates of comorbid depression and anxiety.…”

Section: Introductionmentioning

confidence: 99%

Psychological treatment of depression and anxiety in patients with co‐morbid personality disorder: A scoping study of trial evidence

French

Turner

Dawson

et al. 2017

Personality & Mental Health

View full text Add to dashboard Cite

It is unclear what the best psychological treatment is for depression and anxiety in people with co-morbid personality disorder. Trials of different psychological treatment options for this patient group have been conducted, but this evidence has not previously been systematically reviewed or critically appraised. We set out to conduct a scoping review in order to describe which psychological therapies appear most effective in treating depression and/or anxiety in patients with co-morbid personality disorder. PsycINFO, Cochrane library trials, Medline and Embase databases were searched for studies involving randomized, controlled, experimental, parallel-arm comparisons, examining any well-defined, psychotherapeutic intervention for adults, in an outpatient setting, with a clearly defined diagnosis of depression and/or anxiety, and co-morbid personality disorder. A total of 1662 papers were identified. Fifteen met criteria for inclusion and were reviewed. There was weak evidence to support the use of cognitive behavioural therapy as a psychological treatment for depression in patients with co-morbid personality disorder. However, the literature is characterized by considerable methodological heterogeneity, and further research is needed before there is sufficient evidence to indicate which psychological treatment would be most effective in treating anxiety and/or depression in this patient group. Copyright © 2017 John Wiley & Sons, Ltd.

show abstract

The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study

Cited by 99 publications

References 28 publications

The Challenge of Transforming the Diagnostic System of Personality Disorders

The Challenge of Transforming the Diagnostic System of Personality Disorders

Structure of DSM‐5 and ICD‐11 personality domains in Iranian community sample

Psychological treatment of depression and anxiety in patients with co‐morbid personality disorder: A scoping study of trial evidence

Contact Info

Product

Resources

About